[Federal Register Volume 76, Number 12 (Wednesday, January 19, 2011)]
[Notices]
[Page 3160]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-942]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances Notice of Registration

    By Notice dated May 28, 2010, and published in the Federal Register 
on June 8, 2010 (75 FR 32505), Meda Pharmaceuticals, Inc. 705 Eldorado 
Street, Decatur, Illinois 62523, made application by letter to the Drug 
Enforcement Administration (DEA) to be registered as an importer of 
Nabilone (7379), a basic class of controlled substance listed in 
schedule II.
    The company plans to import the listed controlled substance as a 
finished drug product in dosage form only for distribution to its 
customers. The company does not import the listed controlled substance 
in bulk active pharmaceutical ingredient (API) form.
    There are no domestic sources of Nabilone in finished drug product 
form available in the United States. The U.S. Food and Drug 
Administration has approved this product for medical use in the United 
States.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and Sec.  952(a), and determined that 
the registration of Meda Pharmaceuticals Inc. to import the basic 
classes of controlled substances is consistent with the public 
interest, and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971. DEA has 
investigated Meda Pharmaceuticals Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 952(a) and Sec.  958(a), and in accordance with 
21 CFR 1301.34, the above named company is granted registration as an 
importer of the basic classes of controlled substances listed.

     Dated: December 20, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-942 Filed 1-18-11; 8:45 am]
BILLING CODE 4410-09-P